Skip to content

Study on Music Intervention of Non-clinical College Students

Study on Music Intervention of Non-clinical College Students

Status
Active, not recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06658431
Enrollment
60
Registered
2024-10-26
Start date
2024-10-24
Completion date
2025-08-20
Last updated
2025-01-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression Anxiety Disorder

Keywords

music therapy

Brief summary

The purpose of this trial is to understand whether a mindfulness-integrated volleyball team sports program can effectively intervene in the mental health of college students. The main questions it aims to answer is: Does the music group effectively intervene in the participants' mental health levels, including indicators such as anxiety and depression? Participants will: Attend a music group once a week for 1.5 hours each session, for a total of 6 weeks. Complete a psychological questionnaire every 3 weeks and a follow-up questionnaire every 2 weeks after the program concludes for twice.

Interventions

BEHAVIORALmusic group therapy

90 minutes music group therapy

Sponsors

Ye Zhiyin
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
16 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Participants aged 16 years or older. * Able to communicate in Mandarin and voluntarily participate in the study. * Agree to consistently participate in each session.

Exclusion criteria

* Disagree to consistently participate in each mindfulness-integrated volleyball course. * Individuals unable to commit to participating in each mindfulness-integrated volleyball course.

Design outcomes

Primary

MeasureTime frameDescription
depressionFrom enrollment to 4 weeks after the end of treatment.Using GAD-7 to investigate the psychological variables of participants, a total of four assessments will be conducted, including T1 pre-test (before the start), with measurement time points at T2 (after 3 weeks of intervention), T3 (after 6 weeks of intervention), T4 (2 weeks after the end), and T5 (4 weeks after the end).
anxietyFrom enrollment to 4 weeks after the end of treatment.Using PHQ-9 to investigate the psychological variables of participants, a total of four assessments will be conducted, including T1 pre-test (before the start), with measurement time points at T2 (after 3 weeks of intervention), T3 (after 6 weeks of intervention), T4 (2 weeks after the end) and T5 (4 weeks after the end).
perceived stressFrom enrollment to 4 weeks after the end of treatment.Using PSS-10 to investigate the psychological variables of participants, a total of four assessments will be conducted, including T1 pre-test (before the start), with measurement time points at T2 (after 3 weeks of intervention), T3 (after 6 weeks of intervention), T4 (2 weeks after the end) and T5 (4 weeks after the end).

Secondary

MeasureTime frameDescription
burnoutFrom enrollment to 4 weeks after the end of treatment.Using MBI-SS-15 to investigate the psychological variables of participants, a total of four assessments will be conducted, including T1 pre-test (before the start), with measurement time points at T2 (after 3 weeks of intervention), T3 (after 6 weeks of intervention), T4 (2 weeks after the end) and T5 (4 weeks after the end).
emotion regulationFrom enrollment to 4 weeks after the end of treatment.Using ERQ-10 to investigate the psychological variables of participants, a total of four assessments will be conducted, including T1 pre-test (before the start), with measurement time points at T2 (after 3 weeks of intervention), T3 (after 6 weeks of intervention), T4 (2 weeks after the end) and T5 (4 weeks after the end).
sleepFrom enrollment to 4 weeks after the end of treatment.Using ISI-7 to investigate the psychological variables of participants, a total of four assessments will be conducted, including T1 pre-test (before the start), with measurement time points at T2 (after 3 weeks of intervention), T3 (after 6 weeks of intervention), T4 (2 weeks after the end) and T5 (4 weeks after the end).
self acceptanceFrom enrollment to 4 weeks after the end of treatment.Using SAQ-16 to investigate the psychological variables of participants, a total of four assessments will be conducted, including T1 pre-test (before the start), with measurement time points at T2 (after 3 weeks of intervention), T3 (after 6 weeks of intervention), T4 (2 weeks after the end) and T5 (4 weeks after the end).
perceived supportFrom enrollment to 4 weeks after the end of treatment.Using MSPSS-6 to investigate the psychological variables of participants, a total of four assessments will be conducted, including T1 pre-test (before the start), with measurement time points at T2 (after 3 weeks of intervention), T3 (after 6 weeks of intervention), T4 (2 weeks after the end) and T5 (4 weeks after the end).
loneliness and social anxietyFrom enrollment to 4 weeks after the end of treatment.Using UCLA Scale to investigate the psychological variables of participants, a total of four assessments will be conducted, including T1 pre-test (before the start), with measurement time points at T2 (after 3 weeks of intervention), T3 (after 6 weeks of intervention), T4 (2 weeks after the end) and T5 (4 weeks after the end).
positive and negative affectiveFrom enrollment to 4 weeks after the end of treatment.Using PANAS-10 to investigate the psychological variables of participants, a total of four assessments will be conducted, including T1 pre-test (before the start), with measurement time points at T2 (after 3 weeks of intervention), T3 (after 6 weeks of intervention), T4 (2 weeks after the end) and T5 (4 weeks after the end).
life satisfactionFrom enrollment to 4 weeks after the end of treatment.Using SWLS-5 to investigate the psychological variables of participants, a total of four assessments will be conducted, including T1 pre-test (before the start), with measurement time points at T2 (after 3 weeks of intervention), T3 (after 6 weeks of intervention), T4 (2 weeks after the end) and T5 (4 weeks after the end).

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026